Asymptomatic and Subclinical Mpox: An Association With Modified Vaccinia Ankara Vaccine
Matthew R. Golden(Public Health – Seattle & King County), Alexander L. Greninger(University of Washington), Jolene Gov(University of Washington), Anna Berzkalns(Public Health – Seattle & King County), Ellora Karmarkar(University of Washington), Chase A. Cannon(Public Health – Seattle & King County), Eric J. Chow(Association of Public Health Laboratories), Julia C. Dombrowski(Public Health – Seattle & King County), Meena S. Ramchandani(Public Health – Seattle & King County), Paul D. Swenson(Public Health – Seattle & King County), Margaret G. Mills(University of Washington), Olusegun O. Soge(University of Washington)
Cited by 4
Related Papers
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
|New England Journal of Medicine|2020|801
The effects of the COVID-19 pandemic on community respiratory virus activity
|Nature Reviews Microbiology|2022|650
Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial Infection
|New England Journal of Medicine|2005|471
Point-of-care testing for COVID-19 using SHERLOCK diagnostics
|medRxiv|2020|336